- Home
- Applications
- usa pennsylvania
- exposure limit
Show results for
Refine by
Exposure Limit Product Applications In Usa Pennsylvania
1 applications found
SFA Therapeutics will begin a Phase 1b trial of patients suffering from Mild to moderate Psoriasis 3Q2020. The study will be conducted in conjunction with Temple University in Philadelphia, PA. Estimated start date is 1 October, ...
BySFA Therapeutics, Inc. based in Jenkintown, PENNSYLVANIA (USA)
